Nectar Social | $10,600,000 | (Jun 6, 2025)
Baobab | $13,702,071 | (Jun 6, 2025)
Signify Bio | $15,000,000 | (Jun 6, 2025)
4FOX Ventures
Switzerland
- Lausanne
- 17/11/2022
- Series A
- $5,000,000
4FOX Ventures is a leading Swiss healthcare and technology focused venture capital team managing a portfolio of over 10 highly innovative and fast-growing companies composed, amongst others, of:
(i) Ecorobotix (https://www.ecorobotix.com/en/);
(ii) Neomedical (https://neo-medical.com/);
(iii) Giotto Compliance (https://giotto.ai/);
(iv) Aspivix (https://www.aspivix.com/);
(v) Artiria Medical (https://artiria-medical.com/);
(vi) Positrigo (https://www.positrigo.com/);
(vii) Vima (https://vima-swiss.com/);
(viii) Faveeo (https://www.faveeo.com/);
(ix) Kairos (https://www.kairosfire.com/);
(x) Scailyte (https://scailyte.com/).
We usually invest as first institutional investor in early stage Swiss companies with potential to develop and tackle early on the booming Asian market.
Through active board representation, we deliver direct operational and industry support.
- Industry Venture Capital and Private Equity Principals
- Website http://4fox-ventures.com/
- LinkedIn https://www.linkedin.com/company/4fox-ventures/
Voltrac | $2,286,772 | (Jun 6, 2025)
Rosebud | $6,000,000 | (Jun 6, 2025)
Allay Therapeutics | $57,500,000 | (Jun 6, 2025)
Impart Security | $12,000,000 | (Jun 6, 2025)
Flank | $10,000,000 | (Jun 6, 2025)
Obvio | $22,000,000 | (Jun 5, 2025)
Filament Syfter | $4,800,000 | (Jun 5, 2025)
Vivrelle | $62,000,000 | (Jun 5, 2025)
Sema4.ai | $25,000,000 | (Jun 5, 2025)